Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase by Neil R. Aggarwal, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, David A. Mayer, Kyle C. Molina, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Adit A. Ginde

Get full text

Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5 by Kyle C. Molina, Victoria Kennerley, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, David A. Mayer, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Neil R. Aggarwal, Adit A. Ginde

Get full text

Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID‐19 by Sarah K. Wendel, Adane F. Wogu, Nichole E. Carlson, Laurel Beaty, Tellen D. Bennett, Kelly Bookman, David A. Mayer, Sean S. Michael, Kyle C. Molina, Jennifer L. Peers, Seth Russell, Richard D. Zane, Adit A. Ginde

Get full text

Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients by David J. Douin, Adane F. Wogu, Laurel E. Beaty, Nichole E. Carlson, Tellen D. Bennett, Neil R. Aggarwal, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey Steele, Jennifer L. Peers, Kyle C. Molina, Matthew K. Wynia, Adit A. Ginde

Get full text

Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study by Elaine L. Hill, Hemalkumar B. Mehta, Suchetha Sharma, Klint Mane, Sharad Kumar Singh, Catherine Xie, Emily Cathey, Johanna Loomba, Seth Russell, Heidi Spratt, Peter E. DeWitt, Nariman Ammar, Charisse Madlock-Brown, Donald Brown, Julie A. McMurry, Christopher G. Chute, Melissa A. Haendel, Richard Moffitt, Emily R. Pfaff, Tellen D. Bennett, on behalf of the N3C Consortium, and the RECOVER Consortium

Get full text